Pricing Log in Create free account

Armata Pharmaceuticals, Inc. (ARMP) vs Minerva Neurosciences, Inc (NERV)

Armata Pharmaceuticals, Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Minerva Neurosciences, Inc are of similar size ($111.5M and $109.8M). Minerva Neurosciences, Inc has the higher net margin (0.00% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 13 metrics below, Armata Pharmaceuticals, Inc. leads on 7 and Minerva Neurosciences, Inc on 6.

Valuation

Metric ARMP NERV Biotechnology median
P/E n/m n/m 10.60
P/S 22.34 n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 69.17 n/m 9.02
Earnings yield (157.57%) (1,172.31%) (32.88%)
Free cash flow yield (20.83%) (23.31%) (23.13%)

Profitability

Metric ARMP NERV Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (734.19%) 0.00% 0.00%
Net margin (3,467.04%) 0.00% 0.00%
Free cash flow margin (465.34%) 0.00% 0.00%
Return on equity 127.83% 322.05% (51.96%)
Return on assets (225.11%) (629.71%) (46.06%)
Return on invested capital (89.61%) 0.00% 0.00%

Growth

Metric ARMP NERV Biotechnology median
Revenue growth (TTM) (19.29%) — 6.76%
EPS growth (last fiscal year) (440.18%) (18,347.37%) 29.88%
Revenue growth, 5-year CAGR 42.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP NERV Biotechnology median
Debt to equity (1.23) 0.00 0.00
Current ratio 0.11 20.14 4.97
Net debt to EBITDA (7.07) 5.46 1.01

Dividend

Metric ARMP NERV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARMP NERV Biotechnology median
Market cap 111.54m 109.82m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack